News Focus
News Focus
Followers 6
Posts 556
Boards Moderated 0
Alias Born 06/30/2023

Re: None

Tuesday, 07/22/2025 8:41:45 PM

Tuesday, July 22, 2025 8:41:45 PM

Post# of 3116
Vinay Prasad......So far he's surprised everyone with 4 totally out of left field unexpected new drug Rejections in the last 2 or 3 weeks. Time for the adults to do an intervention, I think.

https://th.bing.com/th/id/ODL.5354b6cef0754d57aa34c9e587097c67?w=252&h=320&c=10&rs=1&o=6&dpr=1.8&pid=AlgoBlockDebug

Bobby?....Donny?.....Congress?

AI: "Yes, Vinay Prasad, the Director of the FDA's Center for Biologics Evaluation and Research (CBER), reportedly oversaw the rejection of Capricor Therapeutics' cell therapy (deramiocel) for Duchenne muscular dystrophy (DMD).
According to reports, Nicole Verdun, the former top regulator of cell and gene therapies within CBER, had scheduled an advisory committee meeting to review the therapy, but Prasad, who was skeptical of the treatment, unilaterally canceled the meeting."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRPT News